{
    "Trade/Device Name(s)": [
        "ID NOW Influenza A & B 2",
        "Alere\u2122 i Influenza A & B 2"
    ],
    "Submitter Information": "Abbott Diagnostics Scarborough, Inc.",
    "510(k) Number": "K191534",
    "Predicate Device Reference 510(k) Number(s)": [
        "K190204"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OZE",
        "OOI"
    ],
    "Summary Letter Date": "July 11, 2019",
    "Summary Letter Received Date": "June 12, 2019",
    "Submission Date": "June 7, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory Viral Panel Multiplex Nucleic Acid Assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal swab eluted in viral transport media",
        "Nasopharyngeal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Viral transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "ID NOW Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Molecular detection",
        "Fluorescence-based detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for ID NOW Influenza A & B 2 rapid molecular test using isothermal amplification for qualitative detection of influenza A and B viral RNA",
    "Indications for Use Summary": "Rapid molecular in vitro diagnostic test for qualitative detection and differentiation of influenza A and B viral RNA in direct or eluted nasal/nasopharyngeal swabs from symptomatic patients, aiding differential diagnosis in conjunction with clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}